Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease.  Pediatric Nephrology.  33:325-333. 2018
2017 Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies.  Pediatric Nephrology.  32:743-751. 2017
2016 Smaller circuits for smaller patients: improving renal support therapy with Aquadex™.  Pediatric Nephrology.  31:853-860. 2016
2015 Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.  Clinical Journal of the American Society of Nephrology.  10:571-577. 2015
2014 Expanding the phenotype of proteinuria in Dent disease. A case series.  Pediatric Nephrology.  29:2051-2054. 2014
2014 Uric acid and the kidney.  Pediatric Nephrology.  29:999-1008. 2014
2012 An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects.  Pediatric Nephrology.  27:1953-1959. 2012
2008 IgA Nephropathy in children and adults: Comparison of histologic features and clinical outcomes.  Nephrology Dialysis Transplantation.  23:2537-2545. 2008
2006 Sodium modeling attenuates rises in whole-blood viscosity during chronic hemodialysis in children with large inter-dialytic weight gain.  Pediatric Nephrology.  21:1179-1184. 2006
2003 Stages of status epilepticus in the developing brain.  Epilepsy Research.  55:9-19. 2003

Principal Investigator On

  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2020 - 2022
  • Private Grant  awarded by Genentech 2018 - 2021
  • Private Grant  awarded by Sanofi US Services Inc 2017 - 2021
  • Chronic Kidney Disease in Children CKID IV  awarded by CHILDREN'S MERCY HOSPITAL 2018 - 2021
  • NAPRTCS Registry of Children Receiving Renal Allografts, Dialysis, or Treatment for Chronic Renal Insufficiency  awarded by NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT TRIALS AND COLLABORATIVE STUDY 2010 - 2021
  • The Child-Centered Outcomes in Practice and Research (COPR) Center of Excellence: Strengthing the Clinical Validity Evidence Base for PROMIS Measures in Chronically Ill Children  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2015 - 2019
  • Private Grant  awarded by VIFOR 2016 - 2019
  • Chronic Kidney Disease in Children (CKiD III)  awarded by CHILDREN'S MERCY HOSPITAL 2013 - 2018
  • International Pediatric Peritoneal Biopsy Study in Children  awarded by UNIVERSITY OF HEIDELBERG 2015 - 2016
  • Private Grant  awarded by ROCKWELL MEDICAL, INC. 2015 - 2016
  • Private Grant  awarded by Genzyme Corporation 2012 - 2015
  • Private Grant  awarded by ABBVIE INC 2013 - 2015
  • Private Grant  awarded by AMGEN, INC.^ 2011 - 2014
  • Private Grant  awarded by AMGEN, INC.^ 2010 - 2014
  • Private Grant  awarded by AMGEN, INC.^ 2011 - 2014
  • Private Grant  awarded by ABBVIE INC 2010 - 2013
  • Chronic Kidney Disease in Children  awarded by CHILDREN'S MERCY HOSPITAL 2010 - 2013
  • Randomized Intervention for Children with Vesicoureteral Reflux  awarded by Wayne State University 2010 - 2013

    • Investigator On

  • Private Grant  awarded by WATERMARK RESEARCH PARTNERS INC 2021 - 2023
  • Kidney Undergraduate Research Experience (KURE)  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • Reaching Equity for Adults and CHildren in Transplant (REACH-TRANSPLANT  awarded by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO 2020 - 2021
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2019
  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL 2014 - 2019
  • Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury  awarded by CINCINNATI CHILDREN'S HOSPITAL 2015 - 2019
  • Private Grant  awarded by OCTAPHARMA - NEW 2016 - 2019
  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL 2015 - 2018
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2016 - 2018
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2018
  • Private Grant  awarded by RETROPHIN, INC. 2014 - 2017
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2016 - 2017
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2017
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2014 - 2016
  • The Genetic Contribution to Drug Induced Renal lnjury:The Drug Induced Renal Injury Consortium (DIRECT)  awarded by INTERNATIONAL SAE CONSORTIOUM, LTD 2013 - 2016
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2013 - 2015
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2015
  • Viral Triggers of Alioimmunity and Autoimmunity in Pediatric Lung Transplantation  awarded by Washington University 2012 - 2013
  • Novel Therapies for Chronic Allograft Dysfunction in Children  awarded by CHILDREN'S HOSPITAL (BOSTON) 2012 - 2013

    • Education And Training

  • Doctor of Medicine, 2008
  • American University of Beirut Medical Center, Internship 1997
  • Cook County Hospital, Residency 2002
  • American University of Beirut Medical Center, Residency 1999
  • Children's Memorial Hospital, Postdoctoral Fellowship 2005
  • University of Texas Southwestern Medical Center, Postdoctoral Fellowship 2000

    • Full Name

  • Sahar Fathallah-Shaykh